ライフサイエンスコーパス: -matched

1 patients and 169,344 propensity score (1:3)-matched non-HCV patients, we examined the association of

2 merized and murinized DTA-1 Abs on a C57BL/6-matched IgG2c isotype resulted in reduced development an

3 Age-matched and sex-frequency-matched community controls wer

4 Age-matched nBmp2NLS(tm) and wild type mice were analyzed by

5 Age-matched virgin (i.e., nulliparous) and multiparous mice

6 Age-matched, cage-dwelling, Veh- and Tam-treated mice withou

7 Age-matched, overweight males consumed 9 d of a high-fat, lo

8 In 17 patients and 10 age-matched non-smoking control subjects we examined brachia

9 years; 64.7% female) and 204 eyes of 102 age-matched noncarriers (mean [SD] age, 67.1 [11.8] years; 5

10 104 cases were compared with 104 age-matched hospital controls.

11 ics, 74 younger asthma patients, and 114 age-matched controls were recruited.

12 rtex using the Golgi-Cox technique in 12 age-matched pathology-free controls, 8 controls with AD path

13 Nineteen patients with sepsis and 19 age-matched healthy controls.

14 males with slowly-progressing CKD, and 2 age-matched controls.

15 newly diagnosed Parkinson disease and 20 age-matched control subjects were recruited.

16 43 moderate-to-severe AD patients and 30 age-matched controls.

17 with complex CHD prior to surgery and 30 age-matched healthy controls using brain MRI.

18 A total of 30 perimetric glaucoma and 30 age-matched normal participants were included.

19 -H2O (370 MBq) scans were obtained in 35 age-matched elderly subjects, including 10 probable AD, 15 a

20 ing in 36 female patients with AN and 36 age-matched healthy volunteers (12-24 years).

21 cluded in the study, together with 2,412 age-matched individuals from the general population.

22 immunologic failed grafts; along with 43 age-matched control eyes) were imaged using high-definition

23 In addition, 49 age-matched control individuals with noninflammatory dermato

24 sorder, 26 with bipolar disorder) and 50 age-matched healthy control subjects.

25 Control subjects were 55 age-matched (+/- 2 years) girls with no clinical hyperandrog

26 d post-GBCA exposure comparisons) and 57 age-matched GBCA-naive control subjects.

27 ion in 59 patients with cirrhosis and 59 age-matched controls.

28 ariant of primary progressive aphasia, 6 age-matched patients with AD, and 6 control subjects underwe

29 ns (MBGs) in 65 children with ASD and 65 age-matched typically developing (TD) children were compared

30 diagnosed from 2009 to 2012, and 192,838 age-matched men free of prostate cancer.

31 d and adolescent cancer survivors and an age-matched comparison group.

32 athletes (N=33, aged 34-71 years) and an age-matched sample of comparison participants (N=18) were ad

33 onic health record to conduct a sex- and age-matched case-control study to evaluate the association b

34 ned severe and very severe pneumonia and age-matched community controls.

35 ma samples from neonatal PA patients and age-matched control individuals identified a set of differen

36 ORAD score, 55 and 65, respectively) and age-matched control subjects (15 children and 27 adults).

37 with Alzheimer disease (AD, n = 14) and age-matched controls (n = 30).

38 nswimming athletes (n = 38) and sex- and age-matched controls (n = 50).

39 term without perinatal brain injury, and age-matched controls born at full term using [18F]-DOPA PET

40 uid collected from glaucoma patients and age-matched controls followed by functional pathway and prot

41 ison with eyes with nonexudative AMD and age-matched controls, and to evaluate prospectively the inci

42 ssive NHL from 2000 to 2010 and sex- and age-matched general-population controls.

43 In this study, seventeen patients and age-matched healthy controls (HC) performed a variant of the

44 dren with AD, ADHD, comorbid AD/ADHD and age-matched healthy controls and to investigate aspects of A

45 s with sporadic Parkinson's disease, and age-matched healthy controls seen from November, 2012, to Ma

46 e with sporadic Parkinson's disease, and age-matched healthy controls, all aged 18 years or older.

47 le with sporadic Parkinson's disease and age-matched healthy controls.

48 rgical TLE patients (7 MRI-negative) and age-matched healthy volunteers were scanned at 7T.

49 been clinically stable for 6 months, and age-matched healthy volunteers.

50 with 4.6 +/- 1.4 mL/cm(3) of a sex- and age-matched MAB.

51 Using Ixodes scapularis ticks and age-matched mice purchased from two independent commercial v

52 male and female late-stage R6/2 mice and age-matched wild-type controls.

53 Patients were eligible for inclusion as age-matched controls if they were treated for lymphoma, rece

54 with first-episode psychosis as well as age-matched healthy control subjects with magnetic resonance

55 arents of 99 unilateral and 56 bilateral age-matched case-control pairs were interviewed by telephone

56 fter treatment with chemotherapy than do age-matched noncancer controls.

57 epatobiliary disorders (BHD) and 20 from age-matched "normal controls"(NC).

58 Samples from age-matched non-neuropathic individuals were used as control

59 th HB at three treatment stages, 30 from age-matched patients with benign hepatobiliary disorders (BH

60 Z in aged bumble mice were distinct from age-matched wild-type MZ B cells.

61 ptomatic patients with HD and 15 healthy age-matched control individuals underwent positron emission

62 67+/-15 years, 20 female) and 10 healthy age-matched controls (69+/-5 years, 5 female) were prospecti

63 e patients), and 16 eyes from 12 healthy age-matched controls (mean [SD] age, 57.9 [8.1] years; 8 wer

64 ic patients, and 16 eyes from 12 healthy age-matched controls, all at the New England Eye Center in B

65 h relapsing-remitting MS and 30 healthy, age-matched control participants were enrolled in the study.

66 etinopathy, and 44.4 (8.3) microL/min in age-matched healthy eyes.

67 All studies were conducted in age-matched, male mice consuming alcohol-containing liquid d

68 The controls included age-matched healthy full-term children.

69 mission prediction in three independent, age-matched data sets, respectively.

70 ONA subjects, and 30 mild-to-moderate LA age-matched patients participated in a cross-sectional study

71 s hospital-based surveillance and nested age-matched case-control study, we did laboratory investigat

72 to train nine patients with PD and nine age-matched controls with multidirectional waist-pull pertur

73 r RSV infection, and healthy noninfected age-matched controls (n = 18).

74 ans in the BPES sample and in a group of age-matched subjects imaged for nonorbital diseases.

75 than patients with either mild sepsis or age-matched healthy controls (15.7 vs 49.5 vs 66.5 nmol/L; p

76 fed a high-fat diet for 12-14 weeks, or age-matched lean controls.

77 T with FKBP1b substantially outperformed age-matched vector controls and performed similarly to each

78 Seventy-seven age-matched controls with normal cognitive function also und

79 l as isoproterenol-challenged heart than age-matched wild type mice.

80 e significantly lower than those for the age-matched controls (median = 0.54 right eye and 0.53 left

81 s apoptotic beta-cells compared with the age-matched wild-type (WT) controls.

82 tivity in dermal fibroblasts compared to age-matched control samples.

83 n = 16 and 28, respectively) relative to age-matched controls (n = 30).

84 of interest identified in comparison to age-matched controls showed significant differences between

85 and in sporadic AD subjects compared to age-matched controls.

86 reduced by 50% or more when compared to age-matched controls.

87 ered functional connectivity compared to age-matched controls.

88 rated increased mtDNA damage relative to age-matched controls.

89 nts post mortem was observed compared to age-matched controls.

90 egions of rats with tinnitus compared to age-matched controls.

91 ementum density ( P = 0.009) compared to age-matched healthy control teeth.

92 5) in women suffering rUTIs, compared to age-matched healthy controls with concentrations further dec

93 decreased amyloid pathology compared to age-matched healthy controls, confirming our experimental re

94 ity in human glaucomatous AH compared to age-matched normotensive control AH.

95 ) greater in young ASD cases compared to age-matched TD controls (<18 years old) and (b) decreases in

96 and serum biochemistry, and compared to age-matched wild-type (Cdc73(+/+) and Cdc73(+/+)/PTH-Cre) li

97 Twelve age-matched healthy control subjects had 11C-Pittsburgh comp

98 ed with methotrexate and eight untreated age-matched control subjects by using Wilcoxon rank-sum test

99 ated decrease in muscle T2 compared with age-matched B10-mdx muscles.

100 7.88 years; 27 females) as compared with age-matched control subjects without diabetes (n = 26; mean

101 MA in eyes affected by AMD compared with age-matched controls and no difference in the rate of de nov

102 ible to SARS-CoV infection compared with age-matched females.

103 double knockout mice were compared with age-matched hyperglycemic ApoE(-/-) littermates.

104 nduced obese (DIO) mice as compared with age-matched lean controls.

105 e in premenopausal females compared with age-matched males.

106 2-months-old APP(E693Q) as compared with age-matched non-transgenic littermates, and western blots sh

107 ubbasal nerve density when compared with age-matched normal mice.

108 the death of their spouse compared with age-matched peers who had also lost their spouse and who had

109 microarray profiling in comparison with age-matched wild-type controls (WTy/WTo).

110 ansplant patients (n = 18), and healthy aged-matched controls (n = 10).

111 ability map that compared patients with aged-matched normative database) and thickness measurements.

112 sample of 2,434 TS cases and 4,093 ancestry-matched controls for rare (< 1% frequency) copy-number v

113 han 30000 cases and more than 45000 ancestry-matched controls.

114 13 European-American cases and 5109 ancestry-matched controls.

115 ted carriage with only 1 of 4 single antigen-matched strains but reduced or prevented nasal colonizat

116 lly and 4 protocols experimentally for batch-matched cell populations, in addition to investigating t

117 n metrics that enable CP to receive a better-matched kidney, without disadvantage to incompatible pai

118 ntify EoE cases and age, sex, and birthplace-matched controls at a 5:1 ratio.

119 Twelve adults with T2DM and 11 age- and BMI-matched control participants without diabetes underwent

120 We identified 13 cases and 56 case-matched controls.

121 22I amyloidosis from nonamyloid HF in a case-matched cohort.

122 t RIC mouse major histocompatibility complex-matched alloHCT model by a process that seems to be driv

123 ne model of major histocompatibility complex-matched multiple minor histocompatibility antigen-mismat

124 ents for risk and postoperative complication-matched patients were significantly lower among hospital

125 re compared with the age-, sex-, and country-matched general population.

126 -infected older adults and a demographically-matched group of uninfected controls performed a verbal

127 black versus white women in the demographics-matched model was 2.05 (95% CI, 1.94 to 2.17).

128 ected HCV-seropositive and incidence density-matched HCV-seronegative participants of the Swiss HIV C

129 ced magnetic resonance (MR) imaging of donor-matched and mismatched stem cell transplants demonstrate

130 ated in an independent cohort study of donor-matched healthy and atherosclerotic human aorta tissue (

131 , 1995, and December 3, 2014, to their donor-matched kidney used in kidney-alone (Ki) or simultaneous

132 ids on employment rate vs age- and education-matched normally sighted controls to guide visual disabi

133 6 BAV cases and 4,660 age, sex and ethnicity-matched controls with replication in up to 1,326 cases a

134 This is a hospital-based, exposure-matched and retrospective longitudinal study.

135 Prospective, fellow eye-matched case series.

136 very severe pneumonia or were age-frequency-matched community controls.

137 Ninety-nine frequency-matched healthy controls underwent testing at commensura

138 Age-matched and sex-frequency-matched community controls were used for comparison.

139 Controls were frequency-matched 2:1 to 12,513 hypertensive women by age and ques

140 Participants were frequency-matched for age, sex, baseline body mass index, and Kell

141 Gender-matched healthy controls (n=68) also underwent MRI scann

142 An age- and gender-matched control nonobstetric population was drawn from a

143 Urbach-Wiethe syndrome with age- and gender-matched control participants (n = 17).

144 n carriers (UMCs), FPAH patients, and gender-matched controls to investigate this variation.

145 oral cancer patients to 242 age- and gender-matched controls using a metagenomic multivariate analys

146 udy of 487 SCC cases and 462 age- and gender-matched controls.

147 , 3, and 5 after injury, and age- and gender-matched controls.

148 ular death) were compared to age- and gender-matched controls.

149 epressed older adults and 52 age- and gender-matched healthy comparison subjects who underwent struct

150 tients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18).

151 PA treatment, compared to 115 age and gender-matched healthy controls).

152 trol group of 31 eyes from 31 age and gender-matched healthy subjects.

153 ences of Ab fucosylation, we produced V-gene-matched recombinant anti-RhD IgG Abs of the four differe

154 der and 32 healthy comparison subjects group-matched on IQ, gender, and age performed a passive avoid

155 ment in animals reconstituted with haplotype-matched hepatocytes, whereas viremia remained stable in

156 AML who underwent HCT from 9/10 or 10/10 HLA-matched unrelated donors.

157 cord blood, 125 HLA-mismatched, and 154 HLA-matched HCTs, detection of multiple viruses was common t

158 diated inhibition in donor selection for HLA-matched HCT may achieve superior graft versus leukemia e

159 5) or RIC (n = 137) followed by HCT from HLA-matched related or unrelated donors.

160 relapse, but capturing alloreactivity in HLA-matched HCT has been elusive.

161 tic syndrome who underwent myeloablative HLA-matched unrelated hematopoietic cell transplantation (HC

162 nt GVHD prophylaxis after myeloablative, HLA-matched related (MRD), or HLA-matched unrelated (MUD) do

163 oablative, HLA-matched related (MRD), or HLA-matched unrelated (MUD) donor T-cell-replete bone marrow

164 tetramer(+) CD4(+) T cells compared with HLA-matched control subjects without diabetes.

165 Controls were hospital-matched and selected by birth certificate.

166 Then, 48 hours later, immune-matched or mismatched stem cells were implanted into ost

167 controls, and stimulated with vaccine-insert-matched peptides.

168 ne children with ADHD and thirty age- and IQ-matched typically developing (TD) controls underwent res

169 47mAb) in the treatment group, or an isotype-matched immunoglobulin in the control group.

170 were collected and used to construct isotype-matched IgG1 antibodies, which were then expressed in ma

171 are observed for films grown on near-lattice-matched substrates MgGa2 O4 and CoGa2 O4 .

172 of extraneous elements or particular lattice-matched substrates.

173 (GaN) DBRs, consisting of perfectly lattice-matched non-polar (11-20) GaN and mesoporous GaN layers

174 onditional mutants were compared with litter-matched controls, global BK knockout, and wild-type mice

175 sing dansyl labeled standard library or mass-matched to chemical structures in human metabolome datab

176 Matrix-matched calibration and a recovery study were carried ou

177 Considering matrix-matched calibration as quantification technique, the rec

178 ernal standard calibration instead of matrix-matched calibration of each sample, and the subsequent i

179 ng matrix effects are observed, thus, matrix-matched calibration is required to reach good performanc

180 0) was achieved for all samples using matrix-matched calibration.

181 eripheral blood HSCT in unrelated, fully MHC-matched Mauritian-origin cynomolgus macaques.

182 Here the authors show that in macaques, MHC-matched iPSC-derived neurons provide better engraftment

183 opy number profiling of primary and multiple-matched metastatic tumours from ten autopsied patients t

184 e and high-dosage gadodiamide and osmolality-matched saline controls.

185 were used-a published data set of 17 patient-matched cases of BrM and a cohort of 7884 BrCa tumors en

186 Given the rarity of patient-matched samples, no exclusion criteria were enacted.

187 he chimeric probe DNA distinguishing perfect-matched and single-mismatched target DNA molecules to th

188 troduced by gas ionization would allow phase-matched dispersive wave generation in the mid-infrared-s

189 gled photon pairs via orthogonal quasi-phase-matched spontaneous parametric downconversion.

190 th JIA (n = 1,298) and age-, sex-, and place-matched controls (n = 5,179).

191 ter exclusion, we identified 1734 propensity-matched patients given rivaroxaban (1751 before propensi

192 ore propensity matching) and 2945 propensity-matched patients given warfarin.

193 We created 3 propensity-matched cohorts of patients with non-valvular atrial fib

194 rthermore, in a Cox model of 3976 propensity-matched pairs, patients who received chemotherapy during

195 In a propensity-matched cohort (median age 82 years, 48% women, median S

196 l cohort study, we used data from propensity-matched patients with relapsing-remitting multiple scler

197 In propensity-matched patients undergoing elective BAV or TAVR, rates

198 Outcomes of propensity-matched groups of patients undergoing elective BAV or TA

199 A multicenter, retrospective, propensity-matched cohort study was conducted in 9 centers of the D

200 Multicenter, retrospective, propensity-matched cohort study.

201 We conducted a retrospective, propensity-matched study using administrative claims data from the

202 h improved 30-day survival in the propensity-matched cohort (20.2% vs 32.9% in non-calcium channel bl

203 The propensity-matched cohort (n = 560, 39.5%) showed similar results.

204 The propensity-matched cohort had similar results.

205 The propensity-matched cohort resulted in a sample of 1,475 patients re

206 Similarly, in the propensity-matched cohort, appropriate empirical treatment was not

207 In the propensity-matched cohort, the overall incidence of POAF was 53.9%.

208 ) months in the NACT group in the propensity-matched cohort.

209 unmatched cohort and 22.8% in the propensity-matched cohort.

210 In this propensity-matched cohort study, we linked nationwide Danish health

211 In this propensity-matched cohort, catheter drainage as first intervention

212 mg BID, or warfarin) using 3-way propensity-matched samples.

213 (nighttime resident model), were propensity-matched (1:1) to patients from August 1, 2013, to Decemb

214 1297 patients receiving BIMA were propensity-matched to 1297 patients receiving SIMA.

215 Among 164 PS-matched patients, support duration was longer for the TC

216 invasive breast cancer and 274 age- and race-matched control subjects who underwent screening FFDM du

217 in mismatched cocultures, exhibiting region-matched astrocyte to neuron communication.

218 compared with age-/sex-/county-of-residence-matched general population controls.

219 Stratified and propensity score-matched analyses to account for confounding by clinician

220 In propensity score-matched analyses, receiving noninvasive ventilation firs

221 nowledge, this is the first propensity score-matched analysis of robotic vs open pancreatoduodenectom

222 l (OS) was examined using a propensity score-matched analysis with a shared frailty Cox regression.

223 interval, 0.84-1.58) or the propensity score-matched cohort (hazard ratio, 0.97; 95% confidence inter

224 Propensity score-matched cohort study analyzing data prospectively collec

225 regression was performed in propensity score-matched cohorts to investigate the outcomes.

226 In propensity score-matched cohorts, partial nephrectomy associated with a s

227 In a propensity score-matched comparison, there was no difference in the prima

228 each case, we identified a propensity score-matched control never initiated on treatment.

229 the risk of dementia using propensity score-matched Cox proportional hazards regression models and K

230 Survival was compared using propensity score-matched groups: patients in the bottom quartile of trave

231 A meta-analysis of all the propensity score-matched observational studies comparing the long-term ou

232 tion with 30-day mortality, propensity score-matched odds ratio (OR) 1.39 (0.76-2.55).

233 Propensity score-matched pairs, subgroups, and sensitivity analyses did n

234 from hospital claims among propensity score-matched patients starting treatment with dabigatran or w

235 Among propensity score-matched patients, we found no difference between regimen

236 results were obtained in a propensity score-matched population.

237 Long-term mortality in the propensity score-matched populations was the primary end point.

238 ugh December 31, 2015, used propensity score-matched regression analysis to compare quarterly changes

239 Propensity score-matched, population-based cohort study.

240 Propensity-score-matched cohorts were constructed to compare death or ser

241 Results In a propensity-score-matched sample of 1,970 individuals, families of patient

242 A state-wide, population-based, self-matched, longitudinal cohort study over a 5-year period

243 esence of ATP hydrolysis even 75 bp sequence-matched strand exchange products remain quite reversible

244 When introduced into an emm serotype-matched invasive strain, the carrier allele (the gene en

245 onsecutive patients with sepsis, 11 severity-matched intensive care patients, and 67 healthy donors w

246 ght to compare natural histories of severity-matched patients with/without subsequent transplantation

247 GVHD patients (n = 14; 28 eyes) and age-/sex-matched healthy controls (n = 14; 28 eyes) were enrolled

248 eatment were compared to 35 healthy age-/sex-matched volunteers.

249 In this pilot study, RA patients and age/sex-matched controls were evaluated for cardiovascular risk

250 ale; mean age of 44 years) and 15 ageand sex-matched controls.

251 related quality of life than an age- and sex-matched control group in the domains of self-care, usual

252 related quality of life than an age- and sex-matched control population.

253 minate patients with NIDCM from age- and sex-matched control subjects.

254 ced (99m)Tc-NaTcO4, whereas the age- and sex-matched controls received a comparable amount of the gen

255 t-degree relatives and pairwise age- and sex-matched controls underwent a comprehensive epilepsy inte

256 rty-five stroke patients and 45 age- and sex-matched controls were recruited.

257 s at 5-years when compared with age- and sex-matched controls.

258 ypertension and 19 normotensive age- and sex-matched controls.

259 L of patients was compared with age- and sex-matched French normal values by using the 36-item Short-

260 ce ratio for HL with respect to age- and sex-matched German reference data was 84.5 (95% CI, 71.2 to

261 ween patients with NOCAD and an age- and sex-matched group of 1347 people from the general population

262 ompared with the results of the age- and sex-matched healthy control participants (n = 20).

263 rolled T2D (HbA1c >7.5%) and 24 age- and sex-matched healthy control subjects were consecutively enro

264 e of 18 patients with ET and 18 age- and sex-matched healthy control subjects.

265 ted from 109 BD patients and 36 age- and sex-matched healthy controls (HCs).

266 nitively-intact patients and 21 age- and sex-matched healthy controls completed a right-hand, paced t

267 ith LAR of recent onset and 115 age- and sex-matched healthy controls prospectively evaluated from 20

268 Eighteen age- and sex-matched healthy subjects served as controls.

269 plant recipients and those from age- and sex-matched healthy volunteers were activated via CD40 and B

270 asures for patients with AF and age- and sex-matched patients with HCM without AF.

271 eart rate (HR) were recorded in age- and sex-matched RA-normotensive (n = 13), RA-hypertensive patien

272 diagnosed synucleinopathies and age- and sex-matched referent participants.

273 were compared with those of 50 age- and sex-matched subjects with HbAA as controls.

274 rom anonymised waste material of age-and-sex-matched individuals (aged >45 years, with a normal blood

275 Compared with sex-matched control animals undergoing spontaneous opioid wi

276 gnificantly increased in comparison with sex-matched controls.

277 ing relaxation-filtered hyperfine and single-matched resonance transfer (SMART) HYSCORE, to detect tw

278 5 ovarian cancer cases and 629 age- and site-matched controls of African-American descent recruited f

279 ns controversy because there is lack of site-matched control for detailed analysis on bone-related pa

280 7 incident lung cancer cases and 807 smoking-matched controls.

281 re measurements were analyzed with spatially-matched histochemical images of HA, collagen and vessel

282 Species-matched CXCR6, CCR5, and GPR15 mediated robust entry int

283 itro Here we investigated the use of species-matched CXCR6 and other alternative coreceptors by SIVag

284 Second, functional imaging during speed-matched execution of trained sequences conducted 48 h af

285 reful murinization and selection of a strain-matched H chain isotype are critical to generate ideal s

286 atory markers, and the microbiome of subject-matched tooth and implant sites during native inflammati

287 We age- and time-matched each sepsis participant with 5 nonsepsis partici

288 iana) seedlings, which were overlaid on time-matched developmental changes.

289 urance were matched to compatible transplant-matched controls and to waitlist-only matched controls o

290 platelet quantitative traits using cell type-matched epigenomic data and promoter long-range interact

291 Shams received volume-matched saline; PE and SU groups received only microsphe

292 tabolomic profiles of breed- and body weight-matched, diabetic (n = 6) and healthy (n = 6) dogs by li

293 have the best outcomes when there is a well-matched donor available because immune complications, su

294 3 children and adolescents with TS to a well-matched group of 103 children without tics.

295 onding and C-H...O hydrogen bonding are well-matched.

296 ng donors were compared with those from well-matched deceased donors.

297 nsplants is not inferior to that of HLA well-matched deceased donor transplants.

298 The extended photoresponse, well-matched energy levels, and high hole mobility from optim

299 The 2 groups were well-matched in terms of baseline characteristics.

300 ABSTRACT: Compared with work-matched high-intensity continuous exercise, intermittent